oham-icmh (Agenda)

Agenda

17th International Conference on Malignancies in HIV/AIDS
October 21-22, 2019
Lister Hill Center Auditorium, National Library of Medicine, NIH

OCTOBER 21st
8:00 AM Poster Set Up (posters will stay up for the entire day)
8:15 AM

Welcome and Introductions

Robert Yarchoan, M.D., Director, Office of HIV and AIDS Malignancy, National Cancer Institute, NIH

8:20 AM

Opening Remarks

Douglas R. Lowy, M.D., Acting Director, National Cancer Institute, NIH

8:30 AM Presentation of NCI Director's Career Achievement Award to Drs. Patrick S. Moore and Yuan Chang
8:35 AM

Plenary: 25 Years of KSHV Research: What Do We Do Now?

Patrick S. Moore, M.D., M.P.H., University of Pittsburgh

9:00 AM - 10:00 AM

Session 1: Kaposi's Sarcoma-Associated Herpesvirus (KSHV)

Moderators: Paul M. Lieberman, Ph.D., The Wistar Institute

Thomas S. Uldrick, M.D., M.S., National Cancer Institute, NIH

O1: Functional Analysis of Human and Viral Circular RNAs During Kaposi's Sarcoma Herpesvirus Infection: Takanobu Tagawa, Ph.D., National Cancer Institute, NIH

O2: KSHV Manipulates Host Iron Metabolism and Antioxidant Pathways to Promote Tumorigenesis and Resist Ferroptotic Cell Death: Ashlee V. Moses, Ph.D., Oregon Health and Science University

O3: Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein-1: Robert Yarchoan, M.D., National Cancer Institute, NIH

O4: Characterizing Somatic Cellular Mutations in KS Tumors: Warren Phipps, M.D., M.P.H., Fred Hutchinson Cancer Research Center                       

10:00 AM Break and Poster Viewing
10:30 AM - 12:00 PM

Session 2: Human Papillomavirus and Associated Diseases

Moderators: Joel M. Palefsky, M.D., FRCP(C), University of California, San Francisco

Mark H. Einstein, M.D., M.S., Rutgers University

Plenary: HPV Latency: John Doorbar, M.D., University of Cambridge

Plenary: Molecular Characteristics of Cervical Cancer in HIV+ and HIV- Ugandan Women: Daniela Gerhard, Ph.D., National Cancer Institute, NIH

O5: HIV Proteins Gp120 and Tat Induce an Epithelial-Mesenchymal Transition in HPR-Immortalized Anal and Cervical Epithelial Cells and Increase Their Migration and Invasion: Sharof Tugizov, Ph.D., D.Sc., D.V.M.

O6: Screening Tests for Anal High-Grade Squamous Intraepithelial Lesion Detection in U.S. Women Living with HIV: Elizabeth Chiao, M.D., M.P.H., Baylor College of Medicine

12:00 PM Lunch (on your own)
1:00 PM Day 1 Poster Viewing (Presenters stand by their poster)
2:00 PM - 3:00 PM

Session 3: HTLV-1 and Other Pathogens

Moderators: Ashlee V. Moses, Ph.D., Oregon Health & Science University

Erle S. Robertson, Ph.D., The University of Pennsylvania

Plenary: HTLV-1 New Strain: Genoveffa Franchini, M.D., National Cancer Institute, NIH

O7: Virus-like Vesicles as a Vaccine Platform for Kaposi's Sarcoma-Associated Herpesvirus: Ting-Ting Wu, Ph.D., University of California, Los Angeles

O8: A CRISPR Screen Reveals Epigenetic Factors that Restrict B-Cell Epstein-Barr Virus Oncoprotein Expression: Benjamin E. Gewurz, M.D., Ph.D., Harvard Medical School

3:00 PM Break and Poster Viewing
3:30 PM - 5:30 PM

Session 4: Prevention of HPV-Associated Cancers and Pathobiology of Lymphoma

Moderators: Elizabeth Y. Chiao, M.D., M.P.H, Baylor College of Medicine

Teresa M. Darragh, M.D., University of California, San Francisco

Plenary: ANCHOR Trial Update: Joel Palefsky, M.D., FRCP, University of California, San Francisco

Plenary: Recent Trends in Anal Cancer Incidence: Implications for Prevention Using Disease Simulation Modeling: Ashish Deshmukh, Ph.D., M.P.H., University of Texas Health Science Center at Houston

Plenary: Evaluation of Cervical Images for Cancer Screening Using Artificial Intelligence Algorithms: Mark Schiffman, M.D., M.P.H., National Cancer Institute, NIH

O9: PD-L1* B-Regulatory Cells are Induced by Exposure to Factors That Are Elevated in HIV-1+ Subjects Who Develop AIDS-NHL: Laura E. Martinez, Ph.D., University of California, Los Angeles

O10: Potential Alternative Survival Mechanisms in HIV-Associated Diffuse Large B Cell Lymphoma (DLBCL) of Germinal Center (GCB) Origin: Alanna Maguire, Ph.D., M.Sc., Mayo Clinic Arizona

 

5:30 PM End of Day One

 

OCTOBER 22nd
8:00 AM Poster Viewing
8:30 AM

Opening Comments

Robert Yarchoan, M.D., Director, Office of HIV and AIDS Malignancy, National Cancer Institute, NIH

Geraldina Dominguez, PhD., Office of HIV and AIDS Malignancy, National Cancer Institute, NIH

8:45 AM - 9:45 AM

Session 5: Cancer Treatment and Outcomes

Moderators: Richard F. Little, M.D., National Cancer Institute, NIH

Richard F. Ambinder, M.D., Ph.D., Johns Hopkins University School of Medicine

Plenary: Cancer Outcomes in Patients With an Underlying HIV Infection: Anna Coghill, Ph.D., M.P.H., Moffitt Cancer Center

Plenary: Cancer in People Living with HIV: Treatment Disparities and Opportunities: Gita Suneja, M.D., M.S.H.P., University of Utah

9:45 AM - 10:45 AM

Roundtable: Cancer Treatment in the Era of cART

Moderator: Richard F. Little, M.D., National Cancer Institute, NIH

Discussants: Richard F. Ambinder, M.D., Ph.D.; Surbhi Grover, M.D., Ph.D.;  Lynda Dee; Thomas S. Uldrick, M.D., M.S.; Elizabeth Y. Chiao, M.D., M.P.H.; Jeff Taylor; and Eric A. Engels, M.D., M.P.H.                         

10:45 AM Break and Poster Viewing
11:15 AM - 12:15 PM

Session 6: Epidemiology

Moderators: Eric A. Engels, M.D., M.P.H., National Cancer Institute, M.P.H.

Keith M. Sigel, M.D., Icahn School of Medicine at Mount Sinai

O11: Factors Associated With Treatment Completion and Treatment Response of Chemoradiation in HIV-Infected Patients in Botswana: Surbhi Grover, M.D., M.P.H., University of Pennsylvania

O12: Cancer-Attributable Mortality Among People With HIV in the United States During 2001-2005: Marie Josephe Horner, Ph.D., National Cancer Institute, NIH

O13: Kaposi's Sarcoma Incidence, Burden, and Prevalence Among Persons With HIV in the United States, 2000-2015: Sally Peprah, Ph.D., National Cancer Institute, NIH

O14: Cancer Immunotherapy Use and Effectiveness in Real-World Patients Living With HIV in the United States, 2000-2015: Blythe J.S. Adamson, Ph.D., M.P.H., Flatiron Health

12:15 PM Lunch (on your own)
1:15 PM Day 2 Poster Viewing (Presenters stand by their poster)
2:15 PM - 3:00 PM

Session 7: Primary Effusion Lymphoma (PEL) Research

Moderator: Denise Whitby, Ph.D., Frederick National Laboratory for Cancer , NIH

Thomas S. Uldrick, M.D., M.S., Fred Hutchinson Cancer Research Center

Plenary: PRIMARY EFFUSION LYMPHOMA: WHAT WE HAVE LEARNED FROM A RARE DISEASE: Ethel Cesarman, M.D., Ph.D., Weill Cornell Medical College

Plenary: Gene Essentiality Landscape and Druggable Genetic Vulnerabilities of Primary Effusion Lymphoma: Eva Gottwein, Ph.D., Northwestern University

3:00 PM Break and Poster Viewing
3:30 PM - 5:30 PM

Session 8: International Studies

Moderators: Charles Wood, Ph.D., University of Nebraska-Lincoln

Erle S. Robertson, Ph.D., University of Pennsylvania Medical School

Plenary: Discerning Clinical and Biological Heterogeneity in Pediatric Kaposi's Sarcoma: Nader El-Mallawany, M.D., Texas Children's Hospital/Baylor College of Medicine

O15: Suspected KSHV Inflammatory Cytokine Syndrome (KICS) in Participants With Mild or Moderate AIDS-KS Enrolled In A5264/AMC067 Is Associated With Inferior Survival: Scott V. Adams, Ph.D., M.P.H., Fred Hutchinson Cancer Research Center

O16: Treatment of Advanced AIDS-Associated Kaposi's Sarcoma (AIDS-KS) in Resource-Limited Settings: A Three-Arm, Randomized, Non-Inferiority Trial in Sub-Saharan Africa and Brazil (ACTG A 5263/AMC066): Susan E. Krown, M.D, AIDS Malignancy Consortium

O17: Poor Immune Cell Infiltration in the Endemic and Epidemic Kaposi's Sarcoma Microenvironment: Salum J. Lidenge, Ph.D., University of Nebraska-Lincoln

O18: Rituximab for Diffuse Large B-cell Lymphoma in Malawi: Matthew Painschab, M.D., The University of North Carolina at Chapel Hill

O19: Cervical Cancer Incidence in Women Living With HIV in South Africa, 2004-2014: Tafadzwa Dhokotera, M.Sc., National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa

5:30 PM Meeting Adjourned